Contractor
RARE DISEASE THERAPEUTICS, INC.
FRANKLIN, TN
- UEI
- M7B1ABSZJKX8
- Parent UEI
- M7B1ABSZJKX8
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$82,0001
Awards
4
Agencies served
2
Active from Mar 26, 2018 to Oct 8, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79726D0158 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Sep 28, 2026 | — |
| 36F79718D0404 CONTRACT AWARD FOR 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS. MDR | Department of Veterans Affairs | — | Mar 26, 2018 | — |
| 75H71226F80033 ANAVORX DISTRIBUTION LLC, ANASCORP ANTIVENOM, WRSU PHARMACY DEPT, DO/TO 26F80033 | Department of Health and Human Services | AZ | Jun 15, 2026 | $82,000 |
| 36E79723A0014 EXERCISE OPTION YEAR 3 - BPA 36E79723A0014 | Department of Veterans Affairs | — | Apr 17, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier M7B1ABSZJKX8, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.